MPS VI
Showing 1 - 25 of 644
MPS IVA, MPS VI Trial in Oakland (Vosoritide Injection [Voxzogo])
Not yet recruiting
- MPS IVA
- MPS VI
- Vosoritide Injection [Voxzogo]
-
Oakland, CaliforniaUCSF Benioff Children's Hospital Oakland
May 4, 2023
MPS I, MPS II, MPS IVA Trial in San Francisco (Aldurazyme (laronidase))
Recruiting
- MPS I
- +8 more
- Aldurazyme (laronidase)
-
San Francisco, CaliforniaUniversity of California
Apr 21, 2022
Mucopolysaccharidosis Type VI Trial in Naples, Ankara (AAV2/8.TBG.hARSB)
Active, not recruiting
- Mucopolysaccharidosis Type VI
- AAV2/8.TBG.hARSB
-
Naples, Italy
- +1 more
Nov 22, 2021
Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI Trial in Torrance (Adalimumab Injection [Humira],
Recruiting
- Mucopolysaccharidosis I
- +2 more
- Adalimumab Injection [Humira]
- Saline Solution for Injection
-
Torrance, CaliforniaThe Lundquist Institute at Harbor-UCLA Medical Center
Aug 9, 2022
MPS (RaDiCo Cohort) (RaDiCo-MPS)
Recruiting
- Mucopolysaccharidosis I
- +7 more
-
Angers, France
- +22 more
Sep 12, 2023
Mucopolysaccharidosis IV A, Mucopolysaccharidosis VI, Mucopolysaccharidoses Trial in Porto Alegre (Losartan, Placebo)
Recruiting
- Mucopolysaccharidosis IV A
- +8 more
- Losartan
- Placebo
-
Porto Alegre, Rio Grande Do Sul, BrazilHospital de Clinicas de Porto Alegre
Oct 2, 2020
Mucopolysaccharidosis VI Clinical Surveillance Program
Completed
- Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome)
-
Irvine, California
- +49 more
Apr 2, 2021
Mucopolysaccharidosis I, II, and VI Screening inHigh-Risk
Terminated
- Mucopolysaccharidosis (MPS)
-
Los Angeles, California
- +13 more
Mar 16, 2021
Bone Disease in Mucopolysaccharidoses (MPS) I, II, and VI
Completed
- Mucopolysaccharidoses
-
Oakland, California
- +2 more
Nov 20, 2019
Brain Structure and Function in MPS Disorders
Completed
- Mucopolysaccharidosis Type I
- +4 more
-
Oakland, California
- +3 more
Sep 4, 2019
Maroteaux-Lamy Syndrome Trial in Minneapolis (Naglazyme®)
Terminated
- Maroteaux-Lamy Syndrome
-
Minneapolis, MinnesotaUniversity of Minnesota Medical Center, Fairview
Dec 22, 2020
Iris Cameras in Mucopolysaccharidoses
Not yet recruiting
- Mucopolysaccharidoses
- Imaging
-
Manchester, United KingdomManchester University NHS Foundation Trust
Aug 30, 2022
Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis IV A Trial in San Francisco (There is no intervention)
Recruiting
- Mucopolysaccharidosis I
- +7 more
- There is no intervention
-
San Francisco, CaliforniaUniversity of California San Francisco
Nov 9, 2022
Set for Head, Neck and Respiratory Disease in
Completed
- Mucopolysaccharidosis Type II
-
Manchester, Lancashire, United KingdomManchester University NHS Foundation Trust
Aug 31, 2023
Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI Trial in Minneapolis (Somatropin (DNA origin))
Terminated
- Mucopolysaccharidosis I
- +2 more
- Somatropin (DNA origin)
-
Minneapolis, MinnesotaUniversity of Minnesota
Aug 6, 2018
Kidney Transplant Rejection Trial (Enteric-Coated Mycophenolate Sodium (EC-MPS))
Not yet recruiting
- Kidney Transplant Rejection
- Enteric-Coated Mycophenolate Sodium (EC-MPS)
- (no location specified)
May 23, 2023
Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)
Active, not recruiting
- Lysosomal Storage Disease
- +4 more
-
Cairo, Egypt
- +4 more
May 17, 2021
Skin Laxity; Facial, Dry Skin; Facial Trial (HydraFacial Syndeo System, ReGen-GF)
Not yet recruiting
- Skin Laxity; Facial
- Dry Skin; Facial
- HydraFacial Syndeo System
- ReGen-GF
- (no location specified)
Jun 27, 2023
MPS-IH (Hurler Syndrome) Trial in Worldwide (Experimental: OTL-203, Active Comparator: Allo-HSCT)
Not yet recruiting
- MPS-IH (Hurler Syndrome)
- Experimental: OTL-203
- Active Comparator: Allo-HSCT
-
Oakland, California
- +6 more
Nov 27, 2023
Glycogen Storage Disease VI, GLYCOGEN STORAGE DISEASE IXa1, GLYCOGEN STORAGE DISEASE IXa2 Trial in Durham (No intervention)
Recruiting
- Glycogen Storage Disease VI
- +4 more
- No intervention
-
Durham, North CarolinaDuke University
Jul 27, 2022
Myofascial Pain Syndrome Trial (Myofascial Pain Syndrome Knowledge and Awareness Questionnaire)
Not yet recruiting
- Myofascial Pain Syndrome
- Myofascial Pain Syndrome Knowledge and Awareness Questionnaire
- (no location specified)
May 21, 2023
Mucopolysaccharidosis Type IIIB, MPS III B Trial in Worldwide (AX 250)
Active, not recruiting
- Mucopolysaccharidosis Type IIIB
- MPS III B
- AX 250
-
Oakland, California
- +7 more
Jan 16, 2023